| JXSL1000010 | 重组人凝血因子VIII融合蛋白 | Recombinant Coagulation Factor Ⅷ Fusion Protein | Other | Biological Products | Import Drug Application | 2010-03-19 | 杭州泰格医药科技有限公司 | Hangzhou Tigermed Consulting Co Ltd;Biogen Inc | Certificate Issued | 2011-12-29 | view |
| JXSL1000009 | 重组人凝血因子VIII融合蛋白 | Recombinant Coagulation Factor Ⅷ Fusion Protein | Other | Biological Products | Import Drug Application | 2010-03-19 | 杭州泰格医药科技有限公司 | Hangzhou Tigermed Consulting Co Ltd;Biogen Inc | Certificate Issued | 2011-12-29 | view |
| JXSL1000007 | 重组人凝血因子VIII融合蛋白 | Recombinant Coagulation Factor Ⅷ Fusion Protein | Other | Biological Products | Import Drug Application | 2010-03-23 | 杭州泰格医药科技有限公司 | Hangzhou Tigermed Consulting Co Ltd;Biogen Inc | Certificate Issued | 2011-12-29 | view |
| JXSL1000008 | 重组人凝血因子VIII融合蛋白 | Recombinant Coagulation Factor Ⅷ Fusion Protein | Other | Biological Products | Import Drug Application | 2010-03-19 | 杭州泰格医药科技有限公司 | Hangzhou Tigermed Consulting Co Ltd;Biogen Inc | Certificate Issued | 2011-12-29 | view |
| JXSS0600040 | 重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(7) | Import Drug Application | 2006-11-08 | 拜耳医药保健有限公司 | Bayer Healthcare Company Ltd;Bayer Healthcare LLC | Certificate Issued | 2007-09-30 | view |
| JXSS0600042 | 重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(7) | Import Drug Application | 2006-11-08 | 拜耳医药保健有限公司 | Bayer Healthcare Company Ltd;Bayer Healthcare LLC | Certificate Issued | 2007-09-30 | view |
| JXSS0600041 | 重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(7) | Import Drug Application | 2006-11-08 | 拜耳医药保健有限公司 | Bayer Healthcare Company Ltd;Bayer Healthcare LLC | Certificate Issued | 2007-09-30 | view |
| JYSB1800190 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2018-09-10 | | Wyeth Farma SA;Pfizer Ltd | Certificate Issued | 2019-02-02 | view |
| JXSL1400062 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2015-01-04 | 精鼎医药研究开发（上海）有限公司 | Parexel China Co Ltd;GC Biopharma Corp | Certificate Issued | 2016-08-01 | view |
| JYSB1800045 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2018-03-23 | | Bayer Healthcare LLC | Certificate Issued | 2018-07-27 | view |
| JYSB2200063 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-04-08 | | Novo Nordisk A/S | | | view |
| JYSB2101080 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2021-07-05 | | Bayer Healthcare LLC | | | view |
| JYSB1900276 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2019-09-28 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | Certificate Issued | 2019-10-28 | view |
| JYSB1800222 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2018-10-25 | 拜耳医药保健有限公司 | Bayer Healthcare Company Ltd;Bayer Healthcare LLC | Certificate Issued | 2018-12-17 | view |
| JYSB1800113 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2018-05-17 | | Baxter AG;Baxalta Manufacturing Sàrl | Filed | 2018-05-30 | view |
| JYSB2200165 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-08-24 | | Bayer Healthcare LLC | | | view |
| JYSB2500024 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2025-02-08 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | | | view |
| CXSL1400063 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(10) | New Drug Application | 2014-07-11 | 正大天晴药业集团股份有限公司 | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | Certificate Issued | 2015-10-29 | view |
| JYSZ1700007 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | License Renew | 2017-03-06 | 惠氏制药有限公司 | Wyeth Pharmaceutical Co Ltd;Wyeth Farma SA;Pfizer Ltd | Certificate Issued | 2018-07-18 | view |
| JYSB2400155 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2024-07-16 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | | | view |
